Journal

Azelaic Acid: The Quiet Multitasker for Tone and Redness

Azelaic acid guide: what the clinical trials show at 10, 15, and 20 percent for rosacea, acne, and pigment, and how it compares with tranexamic acid.


Azelaic acid is a nine carbon dicarboxylic acid. It has been studied for redness, pigment, and clogged pores at once. But its strongest clinical evidence sits at 15 and 20 percent, not the 10 percent sold over the counter. That gap is the most useful thing to understand before buying anything. Below is what each strength has been tested for, and how azelaic acid compares with tranexamic acid for pigment.

What is azelaic acid?

Azelaic acid is a saturated dicarboxylic acid with nine carbon atoms. A 2024 review describes it as non-phenolic and naturally produced by the yeast Malassezia. It also occurs in grains such as wheat, rye, and barley.

That same review sorts its reported activities into five buckets. Antibacterial, anti-keratinizing, antimelanogenic, antioxidant, and anti-inflammatory. Few topical ingredients carry that many separate lines of investigation.

The interest is not new. A 1987 review summarized a decade of work on the molecule. Among the findings: azelaic acid is a reversible inhibitor of tyrosinase and other oxidoreductases in vitro.

How azelaic acid works: five reported activities

Azelaic acid has several documented lines of action. That is why it keeps appearing in unrelated treatment guidelines. Here are the five the 2024 review names.

Pigment. A 2023 pharmacology review lists it as an inhibitor of tyrosinase, mitochondrial respiratory chain enzymes, and DNA synthesis. Tyrosinase is the rate-limiting enzyme in melanin production. A 1996 review argued the pigment effect comes mainly from interference with the energy production and DNA synthesis of hyperactive melanocytes. Antityrosinase activity contributed partially.

Antioxidant activity. The same 2023 review describes azelaic acid as a scavenger of free radicals. It also reports that azelaic acid inhibits the production of reactive oxygen species by neutrophils.

Inflammation. A 2008 review concluded that in rosacea, the main pharmacological action appears to be anti-inflammatory. The proposed route is a reduction in reactive oxygen species. The two activities are treated as linked rather than separate.

Microbes. The 1987 review reported an antimicrobial effect on aerobic and anaerobic organisms. That included the acne bacterium then called Propionibacterium acnes, now called Cutibacterium acnes.

Keratinization. A 1996 rabbit ear model tested three comedolytics on experimentally induced comedones. Twenty percent azelaic acid loosened retention hyperkeratosis within one week. Worth noting honestly: over four weeks, only tretinoin normalized the keratinization process.

Azelaic acid at 10 percent versus 15 and 20 percent

This is where marketing and evidence separate. Commercial topical azelaic acid, across cosmetic and drug status products, spans roughly 5 to 20 percent in gels and creams. So the percentage on the label does not tell you which lane the product sits in.

Intended use decides which regulatory lane a product sits in, and in practice the higher strengths sit behind approved drug applications. That lane decides what evidence exists behind a product.

The 15 percent gel was approved by the FDA in December 2002. The approved use was the inflammatory papules and pustules of mild to moderate rosacea. A 2023 systematic review notes that topical azelaic acid is indicated for acne and rosacea. Those approved products are prescription products.

In US law, a cosmetic and a drug are not separated by the ingredient list. They are separated by intended use, defined in the Federal Food, Drug, and Cosmetic Act definitions. A serum sold to improve the look of skin is a cosmetic. The same molecule in a product sold to treat rosacea lesions is a drug.

Strength Typical US status What the published trials used it for
5 to 10 percent Usually sold as a cosmetic Much thinner randomized evidence than 15 and 20 percent; a small number of trials, mostly in specialty vehicles
15 percent gel or foam Prescription drug Papulopustular rosacea
20 percent cream Prescription drug Acne vulgaris, plus most melasma and pigment studies

The randomized evidence at 10 percent is thin by comparison, but it is not absent. One double-blind randomized controlled trial compared a 10 percent azelaic acid nanocrystal hydrogel against a 20 percent azelaic acid cream. Patients applied roughly 1 gram twice daily for eight weeks for mild to moderate facial acne. At week eight the success rate was 36.51 percent for the 10 percent hydrogel and 30.37 percent for the 20 percent cream. That is one trial, in one engineered vehicle, against the much larger 15 and 20 percent literature.

The practical takeaway is simple. When you read that azelaic acid beat a comparator, check the number. Most results below came from 15 or 20 percent, usually twice daily, over 8 to 15 weeks or longer. A cosmetic strength serum in an ordinary base is a different product held to a different standard.

Azelaic acid for rosacea: what the randomized trials show

Rosacea has the cleanest evidence base of any azelaic acid use.

A 2006 systematic review included five randomized controlled trials covering 873 patients. Standard deviations were missing for four of them, so no meta-analysis was possible. Four of the five showed significant decreases in mean inflammatory lesion count and erythema severity versus vehicle. None showed a significant decrease in telangiectasia severity.

A 2004 review of the 15 percent gel program found the same split. Twice daily azelaic acid beat both its vehicle and metronidazole 0.75 percent gel on inflammatory lesion counts and erythema. But neither active had a clinically discernable effect on telangiectasia. The metronidazole effect plateaued after eight weeks. Azelaic acid kept improving across the 12 to 15 week treatment periods.

The largest synthesis is a 2019 systematic review of 152 studies and 20,944 participants, graded with GRADE. For reducing papules and pustules, it found high-certainty evidence for topical azelaic acid and topical ivermectin. For reducing temporarily persistent erythema, the high-certainty evidence pointed elsewhere, to topical brimonidine.

Read that carefully. It is the whole story of azelaic acid in rosacea. Bumps respond. Background flushing and visible vessels are a different problem with different answers.

Rosacea is a medical diagnosis, and it resembles several other conditions. Get it diagnosed by a board-certified dermatologist rather than self-treating from a symptom list. Do not use mechanical devices on skin with active rosacea. Ask a board-certified dermatologist what is appropriate for your skin.

Azelaic acid for acne and the marks acne leaves behind

A 2021 review of acne management lists topical retinoids, benzoyl peroxide, and azelaic acid among first-line topical treatments. That review puts acne vulgaris at roughly 9 percent of the population worldwide.

The head-to-head data is more mixed than brand copy suggests. A 2020 Cochrane review looked at participants' global assessment of improvement. Azelaic acid was probably less effective than benzoyl peroxide, at a risk ratio of 0.82 with a 95 percent confidence interval of 0.72 to 0.95 in one study of 351 participants. Against tretinoin, the same review found probably little or no difference. That comparison gave a risk ratio of 0.94, confidence interval 0.78 to 1.14, in one study of 289 participants. Across the 49 included trials, treatment lasted longer than eight weeks in 59 percent of studies.

So azelaic acid is a credible first-line option, not the strongest single agent tested. Its appeal is covering acne and pigment in one bottle. That matters if your breakouts leave brown marks behind. Reviews of post-inflammatory hyperpigmentation list azelaic acid among the topical tyrosinase inhibitors used first-line, alongside daily photoprotection. If marks rather than active pimples are the concern, start with our guide on how to fade dark spots.

Azelaic acid vs tranexamic acid for pigment

These two get compared constantly. They are genuinely different tools.

Tranexamic acid acts upstream. It has been described as lightening melasma by interfering with the interaction between melanocytes and keratinocytes, through inhibition of the plasminogen and plasmin system. Azelaic acid acts on the pigment-producing cell itself, through tyrosinase and cell metabolism.

There is one clean head-to-head. A 2023 single-blinded randomized trial compared 20 percent azelaic acid cream against 5 percent tranexamic acid solution. Both were applied twice daily. The target was acne-related post-inflammatory hyperpigmentation, with 30 patients completing each arm over 12 weeks. Both groups improved, and mean post-acne hyperpigmentation index scores were comparable. Side effects were significantly more frequent in the azelaic acid group at week four. By weeks eight and twelve there was no significant difference.

In melasma, a 2019 interventional comparative study put both groups on oral tranexamic acid. One arm added topical 3 percent tranexamic acid, the other topical 20 percent azelaic acid. At six months, mean MASI was 6.06 in the tranexamic acid arm versus 10.62 in the azelaic acid arm. The difference was significant. Note that the schedules differed. The tranexamic arm applied its topical twice daily, the azelaic arm once daily at night.

The tranexamic acid evidence base is also larger for melasma. A 2017 meta-analysis covered 11 studies and 667 participants. Pooling the tranexamic acid only observational studies gave a MASI decrease of 1.60, with a 95 percent confidence interval of 1.20 to 2.00. A 2024 meta-analysis covered 22 randomized trials and 1,280 patients. It reported that oral dosing produced the largest MASI reductions, followed by injection, then topical application.

Factor Azelaic acid Tranexamic acid
Pigment mechanism studied Tyrosinase inhibition, melanocyte metabolism Plasminogen and plasmin pathway, melanocyte and keratinocyte signaling
Also studied for Rosacea papules and pustules, acne Melasma, by oral, topical, and injected routes
Strengths used in trials 15 and 20 percent topical 3 and 5 percent topical, 250 mg twice daily oral
Common early complaint Burning, stinging, tingling, itching Transient skin irritation
Reason to pick it Pigment plus visible inflammation on the same face Pigment with no inflammatory component, especially melasma

A rough decision rule follows from that. If your face has bumps and redness alongside pigment, azelaic acid covers more ground at once. If the problem is pure discoloration, the tranexamic acid literature is deeper. Our longer piece on tranexamic acid in skincare covers routes and formulation. Our tranexamic acid reference page collects the underlying research. To weigh it against the older standard, see tranexamic acid vs hydroquinone.

One historical note still gets quoted constantly. A 1996 review reported that in melasma studies, topical 20 percent azelaic acid was superior to 2 percent hydroquinone and as effective as 4 percent hydroquinone. Note the strength again. That was 20 percent, not a cosmetic serum. Melasma also behaves differently from ordinary sun spots, which we break down in melasma vs hyperpigmentation.

What to expect when you start azelaic acid

Expect some stinging early. The 2004 rosacea review recorded burning, stinging, tingling, and itching as the most frequent treatment-related events. They were described as predominantly transient and mild to moderate.

If a clinician has prescribed the 15 or 20 percent strength, follow their directions on frequency and duration. For a cosmetic strength product, introduce it gradually and judge it over months rather than weeks. For scale, the rosacea programs above ran 12 to 15 weeks. The pigment studies ran 12 weeks to six months.

Azelaic acid is commonly used alongside humectants and niacinamide, though the trials cited here studied it on its own or paired with a prescription partner. Our guide to high-percentage niacinamide covers where that fits. For sequencing several actives without stacking irritation, see how to layer serums.

Daily broad-spectrum sunscreen is not optional for pigment work. Every pigment protocol cited above pairs the active with photoprotection. Unprotected UV exposure undoes the work.

Do not apply azelaic acid to skin just abraded, peeled, or otherwise disrupted by a procedure. Ask the clinician who performed the procedure what is appropriate afterward.

When to see a dermatologist instead of shopping

Rosacea, persistent inflammatory acne, and melasma are medical diagnoses. Each has look-alikes. Each has prescription options that a cosmetic cannot substitute for. The specific 15 and 20 percent products that generated nearly all the evidence above are approved prescription drugs in the United States.

See a board-certified dermatologist for persistent facial redness, flushing, pustules, spreading dark patches, or pigment that returns after fading. A correct diagnosis changes the whole plan. It is also cheaper than a year of guessing.

FAQ

Is 10 percent azelaic acid strong enough to do anything?

The randomized evidence at 10 percent is thin next to the 15 and 20 percent literature. One double-blind trial of a 10 percent nanocrystal hydrogel reported results comparable to a 20 percent cream in mild to moderate acne over eight weeks. That is one trial in one engineered vehicle. Formulation, pH, and base also shape how a percentage behaves, so the number alone never tells the whole story.

Azelaic acid or tranexamic acid for dark spots?

For acne-related post-inflammatory hyperpigmentation, one 12 week randomized trial found 20 percent azelaic acid and 5 percent tranexamic acid produced comparable improvement. Early irritation was more frequent in the azelaic acid arm. For melasma specifically, the tranexamic acid literature is larger, including meta-analyses covering hundreds to more than a thousand patients across oral and topical routes.

Does azelaic acid help with visible blood vessels?

The trials have not shown an effect. The 2006 systematic review found that none of its five included trials showed a significant decrease in telangiectasia severity, and it could not pool them. The 2004 review of the 15 percent gel reported no clinically discernable effect, for azelaic acid or for metronidazole. Visible vessels are usually addressed with light-based or laser approaches. That is a conversation for a dermatologist.

How long before azelaic acid shows a change?

Longer than most people wait. The rosacea trials ran 12 to 15 weeks. One review noted continuous decreases in lesion counts and erythema throughout that period rather than a plateau. Pigment studies commonly ran 12 weeks to six months. Judge it at three months, not three weeks, and take photographs in consistent lighting.

Can azelaic acid be combined with a retinoid?

Azelaic acid is generally used alongside other actives rather than instead of them. One older melasma review noted that tretinoin appeared to enhance its lightening effect, with more skin lightening after three months than azelaic acid alone. Stacking multiple actives still raises irritation risk, especially in the first month. Introduce one new product at a time. Split them across morning and evening if your skin objects.

Does azelaic acid do anything for acne marks, not just active acne?

That is one reason it gets prescribed. Reviews of post-inflammatory hyperpigmentation group azelaic acid with the topical tyrosinase inhibitors used first-line, always alongside sunscreen. A 2023 randomized trial also found 20 percent azelaic acid comparable to 5 percent tranexamic acid on acne-related pigment over 12 weeks. Again, those were 20 percent formulations.


Related reading

  1. Tranexamic Acid in Skincare: The 5% Ceiling Is Chemistry, Not Marketing Ingredients7 min read
  2. Rosacea and Microneedling: Why Caution Comes First Safety11 min read
  3. How to Fade Dark Spots: Why Pigment Clusters, and What Actually Works Skin concerns9 min read